T cell infiltration was correlated with improved survival, while ‘Inflammation’ marker IL6 and ‘Angiogenesis’ marker VEGFA were significantly correlated with poor disease specific survival, the former especially when combined with low levels of IL17 and IL5. This suggests that IL6 promotes tumour growth, which may be suppressed by a Th17 and Th2 response. The gene discussed is IL17A; the disease is neoplasm.